Role of Sodium-Glucose Cotransporter 2 Inhibitor Treatment in Patients With Recurrent Urinary Tract Infections

2025/06/02 by Germán Ramírez‐Olivencia, Germán Ramírez-Olivencia, Manuel Fernández Tomás · 2 voices
Medicine · #Diabetes Treatment and Management

paper · doi:10.1093/cid/ciaf287

openalex publication_date 2025/06/02 · crossref created 2025/06/02 · crossref issued 2025/06/03 · crossref published 2025/06/03 · crossref published-online 2025/06/03 · openalex created_date 2025/10/10 · crossref published-print 2025/12/24 · crossref deposited 2025/12/24 · crossref indexed 2025/12/24 · openalex updated_date 2026/06/26

Citations

• State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women

Discussions

• #IDsky Thought this was a very interesting question re: SGLT2 inhibitors and UTIs. Honestly, I have not been looking for this when I do my assessment. I also missed the 2018 FDA warning with this an [bsky, 5 points, 0 comments]
• Considerations about patients with Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors treatment in recurrent urinary tract infections ✅ Just Accepted #IDSky [bsky, 2 points, 0 comments]